Cumulative Steroid Use and Cardiovascular Events Dr. Mrinalini Dey abstract 1719, Cumulative Glucocorticoid Exposure and Major Adverse Cardiovascular Events in a Cohort of Veterans with Rheumatoid Arthritis: A Nested Case-Control Study, presented at #ACR24.… https://t.co/DqkDgOwsP9 https://t.co/RXRU05UPoh

Best Things I Saw Today in PsA Dr. Catherine Bakewell reviews several studies presented at #ACR24. https://t.co/eIMdoSvkFh https://t.co/aSBEgFegNr

Novel and Emerging Therapies in Psoriatic Arthritis Recent advancements in targeted therapies, including selective inhibitors of key inflammatory pathways, offer promising outcomes for patients with active psoriatic arthritis (PsA). At ACR 2024, there have been further… https://t.co/vBexcBrTQ6 https://t.co/gWpIYKMPnx

Cyclophosphomide vs Mycophenolate vs Tacrolimus in Lupus Nephritis Dr. Mike Putman discusses abstract 0670, presented at #ACR24. https://t.co/aLzsSSOmML https://t.co/XrEtNZAgHI

SELECTing the right patients: upadacitinib in GCA Dr. Brian Jaros reports on abstract 1695, presented at #ACR24. https://t.co/x8lLTviOKk https://t.co/yXwwrdgIyu

Assessment of axSpA Dr. Antoni Chan reviews abstracts 0818 and 0819, presented at #ACR24. https://t.co/2qI6DnnflP https://t.co/BuTdnlMfxq

PsA Ultrasound Updates Dr. Catherine Bakewell and Dr. Lihi Eder discuss updates on ultrasound in psoriatic arthritis at #ACR24. https://t.co/DZBe8uNpJS https://t.co/wIS1hUZnAS

#ACR Best 2024 - Day 4 Although the last day of #ACR24 was but a half day - it was chock full of gems, many coming from the late breaking abstracts presented today. As chosen by the RheumNow faculty, here are some highlight presentations you need to know about.… https://t.co/ws9BOxkZft https://t.co/trMevuvvyX

Methotrexate to Prevent RA, Clear as Mud Intervention in individuals predisposed to rheumatoid arthritis (RA), aiming for prevention, is a significant topic. Seropositivity for rheumatoid factor and ACPA can precede RA by years. Some patients experience a pre-RA arthralgia… https://t.co/D51CoZAzce https://t.co/lgZalnDeb3

Predicting flares in rheumatic diseases with machine learning Rheumatic diseases, such as axial spondyloarthritis (axSpA) and rheumatoid arthritis (RA), are marked by unpredictable disease flares that adversely impact quality of life and long-term outcomes.… https://t.co/6oFRp0zyBw https://t.co/fcMrJOg4mM

Changing Mindsets about Methotrexate Side Effects Dr. Mrinalini Dey discusses abstract 1676, presented at #ACR24. https://t.co/8RXBWUioee https://t.co/liQ1hN4Xtr

How New Medications are Reframing Imaging Abnormalities in axSpA Bimekizumab (BKZ), a monoclonal antibody targeting IL-17A and IL-17F, was evaluated in the BE MOBILE 1 and 2 trials for non-radiographic and radiographic axSpA, respectively. It showed significant clinical… https://t.co/wJYh5XCVfw https://t.co/qZ2MnGVXXG